Delivery Order SPE2DB22D2214-SPE2DB25FS4MM
Award Date
4/4/25
Potential Completion Date
4/7/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,308.39, is for the delivery of OLOPATADINE HCL 0.1% eye drops in 5ml quantities. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Olopatadine HCL 0.1% eye drops, a prescription medication, with a ceiling value of $1,305.12 and a performance period through June 2025. The contract is a delivery order, with a firm fixed price pricing type, and is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,009.00 for the procurement of Olopatadine HCl 0.1% eye drops in 5 ml containers. The contract has an ultimate completion date of October 31, 2023 and is a Firm Fixed Price agreement. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor for this award, which is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,935.80 firm fixed-price delivery order is for the supply of Olopatadine HCl 0.1% eye drops in 5ml bottles. The contract has an ultimate completion date of September 15, 2022 and was awarded on September 14, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,978.46, is for the supply of Olopatadine HCl 0.1% eye drops, a pharmaceutical product used for the treatment of eye conditions. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,382.67 firm fixed-price delivery order is for the supply of OLOPATADINE 0.1% OS 1S, a prescription eye drop medication. The contract has an ultimate completion date of April 18, 2025 and was awarded on March 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award, valued at $1,911.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4559605390 - Olopatadine HCL 0.1% Eye Drops 5ml. The contract has a firm fixed-price delivery order pricing type and an ultimate completion date of January 17, 2023. This award is a part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,145.60 firm fixed-price delivery order is for the supply of Olopatadine Hydrochloride 0.1% eye drops in 5 milliliter containers. The contract has an ultimate completion date of August 8, 2024 and was awarded on August 7, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,310.09, is for the delivery of Olopatadine HCl 0.1% eye drops in 5ml vials. The contract is a delivery order type with a firm fixed price pricing structure, and the ultimate completion date is December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Olopatadine HCl 0.1% eye drops. The contract has a ceiling value of $2,252.93 and is a firm fixed price delivery order with a period of performance through March 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...